Whitefort Capital Management, LP
NEW YORK, NY · CIK 1884931 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2019 · limited partnership
- Assets managed$1.1bn
- Staff11 · 6 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $1.1bn gross assets
- Websitewhitefortcapital.com
- Form ADV · 2026-03-27SEC adviser record
- Legal entityWHITEFORT CAPITAL MANAGEMENT, LP (US)
$405.7m
reported value
+23.5% vs Q1 2026
19positions
78.5%in top 10
2 new
6 added
4 reduced
2 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARBUTUS BIOPHARMA CORP ABUS | $75.8m18.69% | Added +863.4k |
| ROIVANT SCIENCES LTD ROIV | $36.1m8.89% | Reduced -400.0k |
| JOYY INC JOYY | $34.6m8.54% | Unchanged |
| BALLYS CORPORATION BALY | $33.0m8.14% | Unchanged |
| GENWORTH FINL INC GNW | $29.6m7.31% | Unchanged |
| NEXTNAV INC NN | $28.5m7.01% | Added +1.5m |
| OMNIAB INC OABI | $25.2m6.21% | Reduced -4.0m |
| ZIFF DAVIS INC ZD | $21.9m5.40% | New |
| GANNETT CO INC TDAY | $17.1m4.23% | Reduced -1.1m |
| CADIZ INC CDZI | $16.7m4.11% | Unchanged |
| SURGERY PARTNERS INC SGRY | $15.1m3.73% | Reduced -9.8k |
| PUBMATIC INC PUBM | $14.6m3.59% | Added +420.7k |
| OPKO HEALTH INC OPK 3.75 01.15.29 · principal | $14.1m3.47% | Unchanged |
| INNOVATE CORP VATE | $13.9m3.42% | Unchanged |
| SABLE OFFSHORE CORP SOC | $11.5m2.82% | Added +2.2m |
| OPKO HEALTH INC OPK | $6.8m1.67% | Added +258.1k |
| DOUBLEDOWN INTERACTIVE CO LT DDI | $6.3m1.55% | New |
| OUTBRAIN INC TEAD | $3.5m0.87% | Added +999.1k |
| KESTREL GROUP LTD KG | $1.4m0.36% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| UNIQURE NV QURE | $10.8m657.6k shares |
| NEXTNAV INC | $299.2k47.3k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ARBUTUS BIOPHARMA CORP ABUS · 13G · filed 2026-09-04 | 8.0%≈ $75.8m |
| INNOVATE CORP VATE · 13G · filed 2025-11-14 | 7.8%≈ $19.8m |
| OMNIAB INC OABI · 13G · filed 2026-08-14 | 7.1%≈ $25.2m |